Company Overview and News

 
[Press] 88 Energy Limited: Operations Update

2018-04-06 oilvoice
88 Energy Limited (ASX: 88E) (“88 Energy” or the “Company”) is pleased to announce the following update for its projects located on the North Slope of Alaska.
Upvote Downvote

 
88 Energy completes 3D seismic exploration programme in Alaska

2018-04-06 proactiveinvestors.com.au
88 Energy Limited (LON:88E, ASX:88E) has provided an update on its operations in Alaska, where it has both conventional and shale interests within the Project Icewine acreage.
Upvote Downvote

 
88 Energy notes passing of Burgundy Xploration founder

2018-04-05 proactiveinvestors.com.au
88 Energy Ltd (LON:88E, ASX:88E) has informed investors of the death of Paul Basinski, who was the founder of joint venture partner Burgundy Xploration.
Upvote Downvote

 
88 Energy completes loan refinancing, extends maturity to December 2022

2018-03-26 proactiveinvestors.com.au
Alaska-focused explorer 88 Energy Ltd (LON:88E, ASX: 88E) told investors that it has completed the refinancing of a loan with Bank of America on ‘substantively similar’ terms to the original agreement.
Upvote Downvote

 
88 Energy completed loan refinancing, extending maturity to December 2022

2018-03-26 proactiveinvestors.com.au
Alaska focussed explorer 88 Energy Limited (LON:88E, ASX: 88E) told investors that it has completed the refinancing of a loan with Bank of America, on ‘substantively similar’ terms to the original agreement.
Upvote Downvote

 
88 Energy confirms A$8.1mln injection as share options are exercised

2018-03-08 proactiveinvestors.com.au
88 Energy Ltd (LON:88E, ASX:88E) told investors that 98% of its listed (A$0.02 series) options were exercised before the March 2 expiry, resulting in an A$8.1mln injection of capital into the company.
Upvote Downvote

 
88 Energy confirms A$8.1mln injection after share option were exercised

2018-03-08 proactiveinvestors.com.au
88 Energy Ltd (LON:88E, ASX:88E) told investors that 98% of its listed (A$0.02 series) options were exercised before the March 2 expiry, resulting in an A$8.1mln injection of capital into the company.
Upvote Downvote

 
88 Energy investors need to stay patient as Alaska operations go into hibernation

2017-10-10 proactiveinvestors.com.au
88 Energy Ltd (LON:88E, ASX:88E) needs investors to be patient as it waits to get back to business at Project Icewine in Alaska.
Upvote Downvote

 
88 Energy highlights “significant pressure build-up” in Icewine well

2017-10-10 proactiveinvestors.com.au
88 Energy Limited (LON:88E, ASX:88E) has updated investors on the Icewine project, in Alaska, as it released its most recent quarterly activity report.
Upvote Downvote

 
88 Energy trades 15 million shares in first hour following Icewine update

2017-09-22 proactiveinvestors.com.au
88 Energy Ltd (ASX:88E,LON:88E) is one of the most active stocks on the ASX this morning with 15 million shares changing hands.
Upvote Downvote

 
88 Energy shuts down Icewine-2 programme for Alaskan winter

2017-09-21 proactiveinvestors.com.au
88 Energy Ltd (LON:88E, ASX:88E) has shut-in the Icewine-2 well for the winter, anticipating a new programme starting in April or May 2018.
Upvote Downvote

 
88 Energy is the ASX Most Active in early trade following Icewine update

2017-09-21 proactiveinvestors.com.au
88 Energy Ltd (ASX:88E,AIM:88E) is the most active stock on the ASX in morning trade, and within the first 45 minutes, 46 million shares have changed hands.
Upvote Downvote

 
88 Energy to restart testing of key Alaska well next week

2017-08-17 proactiveinvestors.com.au
88 Energy Limited (LON:88E, ASX:88E) said it is ready re-start flow testing its latest well on Alaska’s North Slope as it confirmed it had increased its landholding in the area.
Upvote Downvote

 
88 Energy release half year results, investors wait for more Icewine-2 news

2017-08-07 proactiveinvestors.com.au
88 Energy Ltd’s (LON:88E, ASX:88E) interim results statement give investors very little in terms of new information as the operational hiatus in Alaska continues.
Upvote Downvote

 
Interim Report

2017-08-04 londonstockexchange
88 Energy Limited (ASX: 88E; AIM: 88E) ("88 Energy" or "the Company") is pleased to announce its interim results for the half year ended 30 June 2017.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...